Video

VIDEO: Myths and truths of gluten-free diets
- Author:
- Whitney McKnight
PHILADELPHIA – Do you have patients with undiagnosed celiac disease or legitimate gluten sensitivity, or are they self-diagnosing with the need to...
Video

VIDEO: Management of difficult-to-treat IBD cases
- Author:
- Whitney McKnight
News

Pediatric mental illness dx, drug prescribing vary widely
- Author:
- Whitney McKnight
A lack of psychiatrists only partially accounted for substantial variations in rates of mental illness diagnosis and prescriptions for...
News

Medicare may expand preventive prediabetes coverage
- Author:
- Whitney McKnight
News

IBD: Chronic, not ‘crisis’ care
- Author:
- Whitney McKnight
Inflammatory bowel disease has gone from being a crisis condition to a chronic one in recent decades. While this model saves costs and creates...
News

Chaplains play important part of integrated palliative care
- Author:
- Whitney McKnight
Hospital chaplains have much to offer psychiatry, according to an expert.
News
Higher levels of function before hip fracture tied to greater fears of falling at 1 year
- Author:
- Whitney McKnight
News
Sweeping mental health reforms head for Senate floor
- Author:
- Whitney McKnight
A proposed package of bipartisan mental health legislation is advancing to the Senate floor, including moves that would allow same-day mental...
News
ABMS approves new addiction medicine subspecialty
- Author:
- Whitney McKnight
Any ABMS board-certified physician will be able to seek subspecialty certification in addiction medicine.
News

Nemolizumab improved most common symptoms in moderate, severe atopic dermatitis
- Author:
- Whitney McKnight
Nemolizumab, an anti-interleukin-31 receptor A monoclonal antibody, was shown to rapidly and consistently improve pruritus, dermatitis, and sleep...
News

Nemolizumab Improved Most Common Symptoms in Moderate, Severe Atopic Dermatitis
- Author:
- Whitney McKnight
Key clinical point: Nemolizumab rapidly and consistently improved pruritus, dermatitis and sleep disturbance in patients with previously...
News

60 weeks of ixekizumab effective, well tolerated in moderate-to-severe plaque psoriasis
- Author:
- Whitney McKnight
After 60 weeks of continuous ixekizumab therapy, patients with moderate-to-severe plaque psoriasis had PASI 75 scores of 87%.
News
Study: Primary care falling short on managing depression
- Author:
- Whitney McKnight
Depression is a top chronic illness treated by primary care physicians, but a new study finds that providers may be ill-equipped to manage it.
News
Vaccine for Treating Genital Herpes Reduced Viral Shedding at 6 Months
- Author:
- Whitney McKnight
Key clinical point: A therapeutic vaccine reduced herpes virus shedding and was associated with reductions in genital lesions. Major finding:...
News
Vaccine for treating genital herpes reduced viral shedding at 6 months
- Author:
- Whitney McKnight
A vaccine intended to treat genital herpes lesions and reduce viral shedding of the herpes simplex virus 2 had significant antiviral activity...